Literature DB >> 8608479

Clinical diagnosis and therapy of cutaneous melanoma in situ.

C Bartoli1, A Bono, C Clemente, I D Del Prato, S Zurrida, N Cascinelli.   

Abstract

BACKGROUND: The frequency of in situ melanoma is increasing, and it is often diagnosed fortuitously by histology.
METHODS: We retrospectively reviewed 121 melanomas in situ in 113 patients with the aim of identifying the clinical features of, and optimal surgical treatment for this cutaneous malignancy. Treatment was limited surgery with 3 mm margins of excision in 69 cases (57%) and wider margins of excision (more than 3 mm) in 52 cases (43%). The lesions had a median diameter of 1 cm (range, 2-35 mm) and were generally macular (92% of cases) asymmetric (87%), with an irregular border (88%) and nonuniform pigmentation (98%), usually in shades of brown (41%) and black (48%). These features had permitted a clinical diagnosis of melanoma or suspected melanoma in 62% of cases and of doubtful nevus in an additional 18% of cases.
RESULTS: At a median follow-up of 4 years, there were six local recurrences (three treated by limited surgery and three by wider excision), all in situ melanomas.
CONCLUSIONS: The typical clinical features of melanoma in situ, which are similar to those of early invasive melanoma, are usually sufficiently distinctive to suggest the clinical diagnosis of melanoma or suspected melanoma. Except for large size and superficially extended lesions (larger than 2 cm), adequate treatment is excision with 3 mm margins, although larger lesions (larger then 2 cm) may have an appreciable incidence of local recurrence.

Entities:  

Mesh:

Year:  1996        PMID: 8608479     DOI: 10.1002/(sici)1097-0142(19960301)77:5<888::aid-cncr12>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Cutaneous melanoma in situ: translational evidence from a large population-based study.

Authors:  Simone Mocellin; Donato Nitti
Journal:  Oncologist       Date:  2011-05-31

Review 2.  Diagnosis and Management of Acral Lentiginous Melanoma.

Authors:  Yoshiyuki Nakamura; Yasuhiro Fujisawa
Journal:  Curr Treat Options Oncol       Date:  2018-06-27

Review 3.  Reporting regression with melanoma in situ: reappraisal of a potential paradox.

Authors:  Alexander M Cartron; Paola C Aldana; Amor Khachemoune
Journal:  Arch Dermatol Res       Date:  2020-07-06       Impact factor: 3.017

4.  CD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.

Authors:  R M Kedl; M Jordan; T Potter; J Kappler; P Marrack; S Dow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

5.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

6.  A clinicopathological correlation of 134 stage 1 and 79 non-invasive cutaneous melanomas presenting over a decade (1984-1993) at the Mater Misericordiae Hospital, Dublin.

Authors:  B O'Donnell; P Dervan; M Codd; F Powell; D Lawlor; S O'Loughlin
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

Review 7.  Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Authors:  Shoichiro Ishizuki; Yoshiyuki Nakamura
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.